Bridgeway Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bridgeway Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$253K	–	1417
2023 Q3	$253K	Sell	500 -15	-3%	-$7.99K	0.01%	1048
2023 Q2	$269K	Buy	515 +15	+3%	+$8.09K	0.01%	1070
2023 Q1	$288K	Hold	500	–	–	0.01%	1018
2022 Q4	$275K	Hold	500	–	–	0.01%	1011
2022 Q3	$254K	Sell	500 -4,500	-90%	-$2.52M	0.01%	1088
2022 Q2	$2.72M	Sell	5,000 -4,120	-45%	-$2.27M	0.06%	452
2022 Q1	$5.39M	Sell	9,120 -21,975	-71%	-$12.6M	0.1%	327
2021 Q4	$20.7M	Buy	31,095 +26,475	+573%	+$16.5M	0.39%	29
2021 Q3	$2.64M	Buy	4,620 +4,120	+824%	+$2.26M	0.05%	510
2021 Q2	$252K	Sell	500 -5,100	-91%	-$2.41M	﹤0.01%	1234
2021 Q1	$2.56M	Buy	5,600 +400	+8%	+$191K	0.05%	502
2020 Q4	$2.42M	Buy	5,200 +4,700	+940%	+$2.2M	0.05%	460
2020 Q3	$221K	Buy	+500	New	+$207K	0.01%	1161
2019 Q1	–	Sell	-21,160	Closed	-$4.74M	–	1400
2018 Q4	$4.74M	Buy	+21,160	New	+$4.96M	0.06%	215
2016 Q4	–	Sell	-1,400	Closed	-$223K	–	1464
2016 Q3	$223K	Hold	1,400	–	–	﹤0.01%	1306
2016 Q2	$207K	Buy	+1,400	New	+$207K	﹤0.01%	1300
2013 Q4	–	Sell	-27,300	Closed	-$2.52M	–	1438
2013 Q3	$2.52M	Buy	27,300 +20,400	+296%	+$1.84M	0.09%	321
2013 Q2	$584K	Buy	+6,900	New	+$574K	0.02%	875

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bridgeway Capital Management's TMO Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 500 shares — an estimated $253K sold.

Bridgeway Capital Management first reported a position in TMO in Q2 2013 and held it in 18 quarters. The position peaked at $20.7M in Q4 2021. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Bridgeway Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 500 Thermo Fisher Scientific shares in Q4 2023, an estimated $253K.
Bridgeway Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 18 quarters.
Bridgeway Capital Management's Thermo Fisher Scientific position peaked at $20.7M in Q4 2021.
2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.